Copyright
©The Author(s) 2020.
World J Diabetes. Nov 15, 2020; 11(11): 540-552
Published online Nov 15, 2020. doi: 10.4239/wjd.v11.i11.540
Published online Nov 15, 2020. doi: 10.4239/wjd.v11.i11.540
Mean | SD | Median | Minimum | Maximum | n | |
Age, yr | 62.12 | 9.49 | 63 | 37 | 86 | 200 |
Duration of diabetes, yr | 11.67 | 6.18 | 11 | 1 | 43 | 196 |
HbA1c, % | 8.32 | 1.26 | 8.20 | 5.60 | 13.60 | 200 |
FPG, mmol/L | 9.82 | 2.88 | 9.60 | 3.40 | 20.30 | 126 |
PPG, mmol/L | 11.17 | 3.23 | 10.90 | 4.50 | 24.30 | 145 |
Urea, mmol/L | 6.38 | 1.83 | 6.10 | 2.80 | 11.80 | 89 |
Creatinine, mmol/L | 73.82 | 20.41 | 71.00 | 29.00 | 163.00 | 159 |
eGFR, mL/min per 1.73 m2 | 85.88 | 19.27 | 90.00 | 28.00 | 125.00 | 128 |
Albuminuria, mg/L | 35.52 | 62.49 | 13.60 | 2 | 418 | 62 |
Cholesterol, mmol/L | 4.89 | 1.21 | 4.80 | 2.60 | 9.50 | 144 |
HDL, mmol/L | 1.24 | 0.51 | 1.15 | 0.60 | 5.60 | 151 |
LDL, mmol/L | 2.60 | 0.97 | 2.50 | 0.80 | 5.30 | 146 |
Triglycerides | 2.41 | 1.38 | 2.00 | 0.70 | 8.60 | 159 |
BMI | 39.41 | 5.49 | 37.90 | 30.00 | 69.00 | 193 |
- Citation: Cigrovski Berkovic M, Bilic-Curcic I, Bozek T, Herman Mahecic D, Klobucar Majanovic S, Canecki-Varzic S, Andric J, Marusic S, Mrzljak A. Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting? World J Diabetes 2020; 11(11): 540-552
- URL: https://www.wjgnet.com/1948-9358/full/v11/i11/540.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i11.540